English Pharmaceutical Industries
Pakistan
Portfolio at a glance
How complete is this profile?
Therapeutic mix
Dosage forms
Deepest brand families
Unit-price positioning vs equivalent products
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Products and presentations
| Brand | Generic | Strength | Form | Pack | Registration | Official price | Unit price | Market position |
|---|---|---|---|---|---|---|---|---|
| Enfal | Cefazolin | 500 mg | Injection | Vial | 040130 | PKR 118.00 | PKR 118.00/vial/unit | Near median |
| Enfal | Cefazolin | 1 g | Injection | Vial | 040131 | PKR 209.50 | PKR 209.50/vial/unit | Near median |
| Enfal | Cefazolin | 250 mg | Injection | Vial | 040129 | PKR 78.67 | PKR 78.67/vial/unit | Near median |
| Engmox | Moxifloxacin | 400 mg | Tablet | 5's | 036144 | PKR 961.00 | PKR 192.20/tablet | 6% above median |
| Engpan | Meropenem | 500 mg | Injection | 1's | 064555 | PKR 1,149.16 | PKR 1,149.16/vial/unit | 45% below median |
| Engsit | Ondansetron | 4 mg | Tablet | 10's | 126331 | PKR 1,065.68 | PKR 106.57/tablet | 15% above median |
| Engsit | Ondansetron | 8 mg | Tablet | 10's | 126332 | PKR 1,776.13 | PKR 177.61/tablet | 6% above median |
| Engsit | Ondansetron | 4 mg/5 mL | Syrup | 50ml | 126333 | PKR 1,032.63 | PKR 20.65/mL | 15% above median |
| Engsit | Ondansetron | 4 g/2 mL | Injection | 5's x2ml | 126334 | PKR 2,885.81 | PKR 288.58/mL | Near median |
| Engsit | Ondansetron | 8 g/4 mL | Injection | 5's x2ml | 126335 | PKR 5,156.19 | PKR 515.62/mL | Near median |
| Engsit | Ondansetron | 4 g/2 mL | Injection | 1's x2ml | 126334 | PKR 577.76 | PKR 288.88/mL | Near median |
| Engsit | Ondansetron | 8 g/4 mL | Injection | 1's x2ml | 126335 | PKR 1,031.24 | PKR 515.62/mL | Near median |
| Engsol | Sodium chloride | 0.9 % | Injection | 5ml | 074239 | PKR 18.27 | PKR 3.65/mL | 300% above median |
| Engsol W/V | Sodium chloride | 0.9 % | Injection | 10mlx100's | 074238 | PKR 973.76 | PKR 0.97/mL | 7% above median |
| Engsunate | Artesunate | 30 mg | Injection | 1's | 092530 | PKR 137.13 | PKR 137.13/vial/unit | Near median |
| Engsunate | Artesunate | 120 mg | Injection | 1's | 092531 | PKR 380.91 | PKR 380.91/vial/unit | 5% below median |
| Enmox | Amoxicillin | 250 mg | Injection | 10 x vial's | 074334 | PKR 476.13 | — | No comparator |
| Enmox | Amoxicillin | 1000 mg | Tablet | 10's | 023753 | PKR 232.16 | PKR 23.22/tablet | Near median |
| Enmox | Amoxicillin | 250 mg | Capsule | 100's | 065933 | PKR 649.80 | PKR 6.50/capsule | 41% below median |
| Enmox | Amoxicillin | 250 mg/5 mL | Suspension | 60ml | 026140 | PKR 110.00 | PKR 1.83/mL | 18% below median |
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.